Glenmark Shells Out A Further $25m To Resolve Civil Price-Fixing Charges
Firm Had Previously Agreed $30m Payout To Settle Criminal Charges Over Pravastatin Last Year
Glenmark Pharmaceuticals has agreed a $25m payout in the US to resolve its alleged liability under the False Claims Act linked to historical price-fixing allegations.
